Cost of Hospital Admissions in Medicare Patients With Atrial Fibrillation Taking Warfarin, Dabigatran, or Rivaroxaban

Letter/Communication

Open access

Mary S Vaughan Sarrazin, Michael Jones, Alexander Mazur, Peter Cram, Padmaja Ayyagari and Elizabeth Chrischilles

Journal of the American College of Cardiology, Vol.69(3), pp.360-362

01/2017

DOI: 10.1016/j.jacc.2016.11.023

PMID: 28104077

Files and links (1)

url

https://doi.org/10.1016/j.jacc.2016.11.023View

Published (Version of record) Open Access

Title: Subtitle: Cost of Hospital Admissions in Medicare Patients With Atrial Fibrillation Taking Warfarin, Dabigatran, or Rivaroxaban
Creators: Mary S Vaughan Sarrazin
Michael Jones
Alexander Mazur
Peter Cram
Padmaja Ayyagari
Elizabeth Chrischilles
Resource Type: Letter/Communication
Publication Details: Journal of the American College of Cardiology, Vol.69(3), pp.360-362
DOI: 10.1016/j.jacc.2016.11.023
PMID: 28104077
NLM abbreviation: J Am Coll Cardiol
ISSN: 0735-1097
eISSN: 1558-3597
Language: English
Date published: 01/2017
Academic Unit: Statistics and Actuarial Science; Pharmacy; Health Management and Policy; Epidemiology; Biostatistics; Public Policy Center (Archive); Internal Medicine
Record Identifier: 9983995059102771

21 Record Views